Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wyatt

Showing results (51-60 of 421) with videos related to

Pageof 43
Sort By:
Biodegradation|June 1, 1995
The development of a novel strategy for the microbial treatment of acrylonitrile effluentsJ M Wyatt, C J Knowles
Kidney International|August 16, 2017
How low can you go? Achieved blood pressure and cardiovascular outcomesChristina M Wyatt, Alfred K Cheung
Kidney International|March 22, 2018
Utility of implantable cardioverter defibrillators in chronic kidney diseasePatrick H Pun, Christina M Wyatt
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1991
Characterization of a subset of human B lymphocytes interacting with natural killer cellsR M Wyatt, J R Dawson
BMJ (Clinical Research Ed.)|December 5, 2008
A case of life threatening postpartum haemorrhageS Macdonald, K Brown, M Wyatt
Expert Opinion on Drug Safety|March 1, 2006
Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infectionChristina M Wyatt, Paul E Klotman
Cancer Research|September 18, 2024
A Paradigm Shift in Tumor Immunology: Th17 Cells and TGFβ in Intestinal Cancer InitiationMegan M Wyatt, Chrystal M Paulos
The Medical Journal of Australia|January 5, 2002
Breaking the back of back painR Buchbinder, D Jolley, M Wyatt
Kidney International|August 28, 2019
Stiripentol for the treatment of primary hyperoxaluria and calcium oxalate nephropathyChristina M Wyatt, Tilman B Drüeke
Kidney International|August 14, 2016
Clinical trials of intensive versus less intensive control of hypertension: HOPE or HYPE?Christina M Wyatt, Glenn M Chertow
Pageof 43

Showing results (51-60 of 421) with videos related to

Sort By:
Pageof 43
Biodegradation|June 1, 1995
The development of a novel strategy for the microbial treatment of acrylonitrile effluentsJ M Wyatt, C J Knowles
Kidney International|August 16, 2017
How low can you go? Achieved blood pressure and cardiovascular outcomesChristina M Wyatt, Alfred K Cheung
Kidney International|March 22, 2018
Utility of implantable cardioverter defibrillators in chronic kidney diseasePatrick H Pun, Christina M Wyatt
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1991
Characterization of a subset of human B lymphocytes interacting with natural killer cellsR M Wyatt, J R Dawson
BMJ (Clinical Research Ed.)|December 5, 2008
A case of life threatening postpartum haemorrhageS Macdonald, K Brown, M Wyatt
Expert Opinion on Drug Safety|March 1, 2006
Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infectionChristina M Wyatt, Paul E Klotman
Cancer Research|September 18, 2024
A Paradigm Shift in Tumor Immunology: Th17 Cells and TGFβ in Intestinal Cancer InitiationMegan M Wyatt, Chrystal M Paulos
The Medical Journal of Australia|January 5, 2002
Breaking the back of back painR Buchbinder, D Jolley, M Wyatt
Kidney International|August 28, 2019
Stiripentol for the treatment of primary hyperoxaluria and calcium oxalate nephropathyChristina M Wyatt, Tilman B Drüeke
Kidney International|August 14, 2016
Clinical trials of intensive versus less intensive control of hypertension: HOPE or HYPE?Christina M Wyatt, Glenn M Chertow
Pageof 43